This pilot study investigated the effectiveness of a daily 14-h metabolic fast (14:10 TRE) combined with a commercial weight management program on body weight and fasting blood glucose (FBG) in individuals with obesity. 78 participants were randomized to 14:10 TRE or 12-h TRE (control). The 14:10 group showed a statistically significant weight loss (-8.5%) and improvement in FBG (-7.6 mg/dl) compared to the control group (-7.1% weight loss, non-significant FBG change). Both interventions showed greater FBG reduction in participants with elevated baseline FBG.
Publisher
Nutrition and Diabetes
Published On
Jan 15, 2021
Authors
Pamela M. Peeke, Frank L. Greenway, Sonja K. Billes, Dachuan Zhang, Ken Fujioka
Tags
metabolic fast
weight loss
blood glucose
obesity
intermittent fasting
clinical trial
energy restriction
Related Publications
Explore these studies to deepen your understanding of the subject.
